Treatment of primary nocturnal enuresis using DDAVP is based upon the hypothesis that antidiuretic hormone (ADH) secretion is insufficient at night. The known efficacy of the treatment on the one hand, and persisting doubts about its theoretical basis on the other, formed the background of the present study. Ten children (mean age 10-5 years) with primary nocturnal enuresis were compared with a corresponding control group of eight patients. Diurnal and nocturnal urine production, ADH secretion, and plasma osmolality were determined. No differences between the two groups were found for urine production, ADH levels during day and night, or plasma osmolality. However, in order to regulate plasma osmolality the enuretic children required a markedly greater output of ADH: 2-87 (95% confidence interval 0-091 to 40.35) pg/ml/mmol/kg v 056 (0.08 to 1.03) in the controls (p<0.01).
In 1975 George et al described the circadian rhythm of antidiuretic hormone (ADH) secretion with its typical nocturnal rise in serum concentration. ' According to the findings of Rittig et al patients with primary nocturnal enuresis do not show this physiological secretion pattern.2 On the basis of their findings, these investigators put forward a hypothesis regarding the aetiology of nocturnal bed wetting. This was attractive because it agreed with the concept that enuretic individuals produce high nocturnal urine volumes of low concentration and it suggested a mechanism of treatment, namely substitution of the antidiuretic hormone that is 'lacking' at night. Intranasal administration of DDAVP is very simple. This type of treatment is a little less successful than conditioning alarms3 but the use of a nasal spray for therapeutic purposes is much easier to explain to a patient.
The undisputed therapeutic benefits3-5 have pushed to the background doubts about the hypothetical lack of ADH rhythmicity.6 It is still uncertain why patients with lowered ADH secretion (neurogenic diabetes insipidus), and thus markedly increased urine volumes, are generally not enuretic. The model can also be criticised for restricting the ADH secretion mechanism as a function of osmolality in such a way that regulation is effective during the day but not at night in patients with enuresis.
The conflict between the unsatisfactory theoretical basis and the therapeutic efficacy of DDAVP has not been resolved. Our prospective single blind study sought to contribute to a solution.
Methods
In order to exclude the age dependent aspect in enuresis, the study comprised children from a very narrow age range. It included 10 patients with primary nocturnal enuresis (eight boys, two girls) and eight control children (seven boys, one girl). The age of the enuretic children was 9 years 4 months to 12 years 10 months (median 10 years 6 months), while the age of the children in the control group was 9 years 5 months to 12 years 2 months (median 11 years 2 months). The median body weight in the control group was 35 7 kg (27-5-47.0 kg) and 41-7 kg (31.2-49.3 kg) in the enuretic children. There were no significant differences between enuretics and controls regarding age, weight, sex ratio, and blood pressure. Clinical examination and the following investigation were normal in all children: urea, creatinine, liver enzyme activity, electrolytes, red and white blood cell counts, urine microscopy and culture.
The patients with primary nocturnal enuresis had received no treatment for four weeks before entry to the trial nor did they suffer from other conditions such as abnormalities or infection of the urinary tract. During a two week run-in period, the enuretic children had had at least three wet nights per week. Fluid intake was restricted to 25 mllkg/24 hours for three days before the trial and to 20 ml/kg/24 hours on the day of the study. This fluid management was chosen in order to allow a comparison with the cited studies.2 3 Urine was collected by spontaneous voiding at the following times: 07, 11, 15, 19, 22, 01, 04, and 07 hours. Venous blood samples were taken simultaneously by means of an indwelling cannula which had been placed the day before. In order to avoid non-osmotic stimulation of ADH, the blood samples were collected after the patients had been in the supine position for 10 minutes without fluid intake. Blood for the ADH assay was withdrawn into chilled EDTA tubes in iced water. Centrifugation and freezing of the supernatant at -22°C was always done immediately after sampling. ADH concentration was measured by radioimmunoassay after extraction (Robertson et al 7 modified according to Rascher et a!8 ; the measurements were done in Professor Rascher's laboratory, Giessen University Hospital of Paediatrics; the analysts did not know to which group the samples were assigned). Repeated tests and calculation of the mean value were performed in every instance. A Roebling osmometer was used to measure osmolality with repeated tests. The arithmetic means of the measurements at 01, 04, and 07 hours were defined as night values, the means of the figures at 11, 15, and 19 hours as day values.
Enuretic patients were given intranasal DDAVP in a nightly dose of 40 mg for 14 days starting on the day after the examination.
The study was approved by the ethics commitee of Christian-Albrechts-University School of Medicine. After receiving detailed information, the parents gave written consent to the study.
The results are presented as median values and 95% confidence intervals of the median. Differences were tested using the nonparametric Wilcoxon ranked paired test. The level of significance was set at p=0 1.
Results
Before the trial and treatment, enuretic children had 5-2 wet nights per week. Six of the 10 patients responded to treatment. A median of 0-7 wet nights per week was found in these children. There were four non-responders who still had five wet nights per week.
URINE BALANCE
In the control group, diuresis during the day was 0-63 (0.34 to 1 01) ml/kg/hour, while it was 0 77 (0 50 tol08) mi/kg/hour in the enuretic children. Diuresis at night was 0-38 (0-26 to 0 73) mikg/hour in control children and 0-48 (0 30 to 0 66) ml/kg/hour in the enuretics. The respective day/night diuresis ratio for the control group was 1-37 (0-91 to 1-85) on average and 1-46 (1-18 to 1 85) for the enuretic children. A nocturnal decrease in urine production was evident in both groups, with no difference between controls and enuretic children. Urine osmolality in the con- Figures 1 and 2 show the mean day and night ADH values for every subject in relation to plasma osmolality. There are two points per subject which are connected by a straight line. The steeper the upward slope, the greater the differences in ADH levels related to the changes in plasma osmolality. A comparison between the absolute slopes of the controls and the enuretics shows a significantly steeper slope for enuretics (p<0 01). It amounts to 0-56 (0-08 to 1-03) pg/ml/mmol/kg in the control group and 2-87 (0.91 to 40 35) pg/ml/mmol/kg in the enuretic group. Contrary to the anticipated nocturnal increase in ADH, we found a daytime rise in ADH in all children, enuretic and nonenuretic. This finding may seem surprising but the children were probably so active in the air conditioned rooms of the ward that cutaneous fluid loss reached a point where it became necessary to regulate excretion by an increase in ADH. The results show that both enuretic and control children were able to do so, reaching constant plasma osmolality.
There is one major difference between the two groups. Enuretic children required substantially greater changes in ADH secretion to regulate osmolality than control patients (figs 1 and 2). It is well known that ADH secretion depends on plasma osmolality.8 12 The steepness of the correlation curve described varies in different studies, ranging from 0-2 to 065 pg/mllmmollkg.13 The values for our control group were in this range. The increases in the enuretic group, on the other hand, differed markedly (2-87 pg/mllmmollkg). Even though the study contained relatively few patients and controls, this difference was significant (p<O0O 1).
Our findings do not solve uncertainties regarding the pathogenesis of enuresis. They do, however, provide evidence against the concept that enuretic individuals have an increased urine volume at night, and they disprove the hypothesis that the capacity to regulate osmolality by adequate ADH secretion is reduced during the night. Our results furnish evidence that the regulating function of ADH secretion differs between enuretic and nonenuretic children. This may be the explanation for the established efficacy of DDAVP treatment. The well known familial disposition towards nocturnal enuresis and the fact that there is a high rate of spontaneous resolution with age are in keeping with this finding because the extent to which ADH secretion and osmolality correlate differs from person to person and also depends on age.'4 The results of this study lead us to speculate that there might be a difference between enuretic children and controls at the ADH receptor level.
